BIOTRONIK’s Implantable Cardiac Defibrillator with Atrial Sensing Receives FDA Approval
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System. This novel device is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead with atrial sensing capabilities.
In the News
None at this time.